EchoTip AcuCore Post-Market Clinical Study
NCT06358001 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 183
Last updated 2025-09-22
Summary
The purpose of collecting this data is to continue to learn more about the EchoTip AcuCore and the device's ability to produce the desired favorable effect and if there are any undesired outcomes that may be related to the EchoTip AcuCore.
Conditions
- Adenocarcinoma
- Neuroendocrine Tumors
- Hepatocellular Carcinoma
- Cholangiocarcinoma
- Malignant Lymphoma
- Metastasis
- Chronic Pancreatitis
- Autoimmune Pancreatitis
Interventions
- DEVICE
-
EchoTip AcuCore
Using endoscopic ultrasound guided needle to collect biopsies
Sponsors & Collaborators
-
Cook Research Incorporated
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-08-05
- Primary Completion
- 2025-06-14
- Completion
- 2025-07-19
Countries
- United States
Study Locations
More Related Trials
-
A Phase II Clinical Study of AK104/AK112 in Combination With TT-00420 Tablet for Advanced HCC.
NCT07052253 ·Status: RECRUITING ·Phase: PHASE2
-
Liver Cancer and Immunotherapy in the Liquid Biopsy Era
NCT05810402 ·Status: RECRUITING ·Phase: NA
-
Effectiveness of Trans-Arterial Chemo Embolization for Hepatocellular Carcinoma on Follow-Up CT Triphasic Liver
NCT07048665 ·Status: ACTIVE_NOT_RECRUITING
-
A Study of the Combination of Anti-PD-1 AK105 and Anlotinib in First-line Hepatocellular Carcinoma (HCC)
NCT04172571 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma
NCT05359861 ·Status: COMPLETED ·Phase: PHASE2
-
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
NCT01015833 ·Status: COMPLETED ·Phase: PHASE3
-
Ambispective Cohort Study of Precision Medicine for Primary Hepatobiliary Cancer Based on Next-generation Sequencing
NCT05520788 ·Status: RECRUITING
-
Cryoablation Combined with Anti-PD-1 Antibody in Patients with Advanced Intrahepatic Cholangiocarcinoma
NCT04299581 ·Status: RECRUITING ·Phase: PHASE2
-
Sacituzumab Govitecan for the Treatment for Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma
NCT06178588 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Individualized Comprehensive Treatment for Advanced Hepatocellular Carcinoma
NCT06893887 ·Status: RECRUITING ·Phase: NA
-
Axitinib as Second-line Treatment for Advanced Hepatocellular Carcinoma
NCT01273662 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety and Efficacy Study of CC-122 in Combination With Nivolumab in Subjects With Unresectable Hepatocellular Carcinoma (HCC)
NCT02859324 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of Ga-68 Dolacga to Evaluate Liver Reserve Function in Patients With HCC Before and After Proton Therapy
NCT06182865 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Application of mRNA Immunotherapy Technology in Hepatitis B Virus-related Refractory Hepatocellular Carcinoma
NCT05738447 ·Status: UNKNOWN ·Phase: PHASE1
-
The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy
NCT04572633 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)
NCT04344158 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study of Anti-PD-1/CTLA-4 Bispecific AK104 Plus Lenvatinib in First-line Advanced Hepatocellular Carcinoma
NCT04444167 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of Circulating Exosome Proteomics In Gallbladder Carcinoma Patients
NCT03581435 ·Status: UNKNOWN
-
Precision Medicine for Combined Hepatocellular-Cholangiocarcinoma
NCT06146127 ·Status: RECRUITING
-
Anti-GPC3 CAR-T for Treating GPC3-positive Advanced Hepatocellular Carcinoma (HCC)
NCT03084380 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Identification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder Cancer
NCT05184400 ·Status: RECRUITING
-
A Study to Evaluate C-CAR031 in Glypican-3 (GPC3)+ Advanced/Recurrent Hepatocellular Carcinoma (HCC)
NCT06590246 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Phase 1 In-vivo Biliary Study of KSP/QRH Heptapeptide Dimer
NCT04304781 ·Status: TERMINATED ·Phase: PHASE1
-
Safety and Effectiveness of BioTraceIO 360 for Planning, Monitoring and Assessment of Liver Tissue Ablation Procedures
NCT05582018 ·Status: TERMINATED ·Phase: NA
-
An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer
NCT06342414 ·Status: RECRUITING